Monoclonal Antibody to Melanoma Marker (MART-1 + gp100 + Tyrosinase)(A103 + HMB45 + T311), Clone: [A103 + HMB45 + T311], Mouse

Catalog Number: ABI-36-11073
Article Name: Monoclonal Antibody to Melanoma Marker (MART-1 + gp100 + Tyrosinase)(A103 + HMB45 + T311), Clone: [A103 + HMB45 + T311], Mouse
Biozol Catalog Number: ABI-36-11073
Supplier Catalog Number: 36-11073
Alternative Catalog Number: ABI-36-11073-100UG
Manufacturer: Abeomics
Host: Mouse
Category: Antikörper
Application: IHC, WB
Species Reactivity: Human
Immunogen: Recombinant hMART-1 protein (A103), Recombinant tyrosinase protein (T311), Extract of pigmented melanoma metastases from lymph nodes (HMB45)
Alternative Names: MLANA||MART1
This antibody cocktail recognizes three melanoma-specific proteins, which include MART-1, Tyrosinase and gp100. MART-1 is a newly identified melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. Tyrosinase is one of the targets for cytotoxic T-cell recognition in melanoma patients. The function of gp100 is not known but it is reported to be a useful marker for melanocytes and melanomas. This cocktail of three markers is designed for extremely sensitive labeling of formalin-fixed, paraffin-embedded melanomas and other tumors showing melanocytic differentiation.
Clonality: Monoclonal
Clone Designation: [A103 + HMB45 + T311]
NCBI: 2315
UniProt: Q16655
Purity: Affinity Chromatography
Form: Purified
Target: Melanoma Marker (MART-1 + gp100 + Tyrosinase)
Application Dilute: Western Blot (2-4ug/ml), Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95&degC followed by cooling at RT for